A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.

Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Ozempic, which accounts for 41% of the company's sales, is an injectable anti-diabetic treatment that became wildly popular ...

A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need ...

Novo Nordisk's U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker's better-than-estimated quarterly results offset slower 2025 sales growth projections amid ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...